SOFTWARE PRODUCT FOR CLINICAL AND IMMUNOLOGICAL PROGNOSIS OF THE SEVERITY OF COVID-19
Abstract
One of the global problems at the moment is the Coronavirus (COVID-19). Everyone already knows all the consequences of COVID-19. In addition, determining the course of the severity of the disease is also an important factor for both the patient and the medical staff. Until now, there are various methods and standards for the treatment of COVID-19. But for determining the severity of the disease, no standard or protocol has yet been defined. To solve this problem, we studied clinical and immunological tests in 109 patients and tried to create a program to predict the severity of COVID-19 in the early stages of the disease, so that, during the treatment for the severity of the disease, we started.
Keywords
COVID-19, software, “CIP-COV.exe”,, cytokines, , immunityHow to Cite
References
Halpin SJ, McIvor C, Whyatt G, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID‐19 infection: a crosssectional evaluation [published online ahead of print July 30, 2020]. J Med Virol. 2020:1‐10. https://doi.org/10.1002/jmv.26368
Kremer N.Sh. Probability theory and mathematical statistics: Textbook for universities. - M., UNITY-DANA, 2001
Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID‐19) outbreak in China: summary of a report of 72,314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239‐1242.
License
Copyright (c) 2021 Nodir Ruzimurodov, Tamara Aripova
This work is licensed under a Creative Commons Attribution 4.0 International License.
The content published on the International Scientific and Current Research Conferences platform, including conference papers, abstracts, and presentations, is made available under an open-access model. Users are free to access, share, and distribute this content, provided that proper attribution is given to the original authors and the source.
